This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: Johns Hopkins University. Active years: 2019.
Company Filing History:
Years Active: 2019
Title: Mark J Soloski: Innovator in Lyme Disease Treatment
Introduction
Mark J Soloski is a notable inventor based in Baltimore, MD (US), recognized for his contributions to the field of Lyme disease treatment. He has developed innovative methods aimed at improving patient outcomes for those at risk of developing post-treatment Lyme disease syndrome (PTLDS). His work is particularly significant in the context of antibiotic therapy for Lyme disease.
Latest Patents
Mark J Soloski holds a patent titled "Elevated CCL19 after completion of therapy for acute Lyme disease identifies patients at risk for development of post-treatment Lyme disease syndrome who will benefit from further antibiotic therapy." This invention provides methods and compositions useful for treating Lyme disease. Specifically, it offers a way to identify patients who may benefit from additional antibiotic treatment based on their CCL19 levels after completing an initial course of antibiotics.
Career Highlights
Throughout his career, Mark has focused on advancing medical treatments for Lyme disease. His innovative approach has the potential to significantly impact patient care and improve the quality of life for those affected by this condition. His dedication to research and development in this area has established him as a key figure in the medical community.
Collaborations
Mark J Soloski collaborates with John N Aucott, a fellow researcher in the field. Their partnership enhances the research efforts aimed at understanding and treating Lyme disease more effectively.
Conclusion
Mark J Soloski's work exemplifies the importance of innovation in medical research, particularly in the treatment of Lyme disease. His contributions are paving the way for improved patient care and outcomes in this challenging area of healthcare.